1. Exploring heparin’s protective mechanism against AGEs induced endothelial injury
- Author
-
Junfeng Shi, Yudong Guan, Hongwei Song, Liang Zhu, Jingjing Li, Qinying Li, Ningning Hou, Fang Han, Meng Wang, Kexin Zhang, Ming Shan, Xiaodong Sun, and Hongyan Qiu
- Subjects
Endocrine system physiology ,Human metabolism ,Cell biology ,Science - Abstract
Summary: Advanced glycation end products (AGEs) in diabetes can cause endothelial damage. Heparin, widely known as a recognized anticoagulant, is also a multifunctional therapeutic drug. This study investigated whether heparin could ameliorate AGEs-induced endothelial injury. Remarkably, heparin effectively attenuated this cellular damage and assumed a reparative role. Furthermore, heparin inhibited the AGEs-RAGE-NFκB axis, thereby mitigating endothelial inflammatory injury. Comprehensive proteome and knockdown experiments suggested that heparin may exert a positive influence on cell growth and further alleviate pathological damage by upregulating the expression of LYAR (cell growth-regulating nucleolar protein). Diabetic mouse model was also used to further verify the changes of endothelial tissue in diabetic state and heparin intervention. In summary, these findings demonstrate that heparin has the potential to ameliorate AGEs-induced endothelial injury, opening new avenues for exploring the expanded therapeutic roles of heparin and its potential application in the management of diabetes and its associated complications.
- Published
- 2024
- Full Text
- View/download PDF